Cardiac arrest & resuscitation

Biomarkers for neuroprognostication after standard versus extracorporeal cardiopulmonary resuscitation – A sub-analysis of Prague-OHCA study

ResuscitationPublished Secondary analysis of the Prague-OHCA randomised trial

An erratum to this article was published (Resuscitation, Aug 2024 ↗)

Authors' conclusion

Biomarkers exhibited similar trajectories although absolute values tended to be higher in ECPR. NSE had superior performance in both groups. PCT showed a good performance specifically in ECPR.

Study context

Population
Patients resuscitated from out-of-hospital cardiac arrest (OHCA)
Participants
92 vs 164
Comparison
Extracorporeal CPR (ECPR) vs standard CPR
  • ECPRn = 92
  • CPRn = 164reference
Primary endpoint
Favourable neurologic survival (CPC 1-2)
Follow-up
180 days

Primary result

As reported in the abstract

Favourable neurologic outcome (CPC 1-2)

P = 0.191

Secondary outcomes

OutcomeCPRECPR
Prognostic performance of NSE (ROC) · 24-48-72 hBest performance in both groups
AUC 24 h0.890.78
AUC 48 h0.90.9
AUC 72 h0.910.9
Prognostic performance of PCT (ROC) · 24-48-72 h
AUC 24 h0.720.84
AUC 48 h0.730.87
AUC 72 h0.730.86

Biomarker trajectories

Similar trajectories in both groups, better values with cerebral performance category (CPC) 1-2
Neuron-specific enolase (NSE), C-reactive protein and neutrophil-to-lymphocyte ratio did not differ between groups

Procalcitonin (PCT), ECPR vs CPR · 24-72 h

Higher in ECPR
all p < 0.01

Platelets, D-dimers and fibrinogen, ECPR vs CPR · 24-72 h

Lower in ECPR
all p < 0.001

Prognostic performance of PCT (ROC) · 24-48-72 h

Optimal cutoff points of NSE and PCT higher in ECPR vs CPR

Original publication

Biomarkers for neuroprognostication after standard versus extracorporeal cardiopulmonary resuscitation – A sub-analysis of Prague-OHCA study. Resuscitation. Published 20 April 2024. doi:10.1016/j.resuscitation.2024.110219

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.